|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 3351558 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17197711.9 |
| Date of filing the European patent application | 2010-11-12 | |
| (97) | Date of publication of the European application | 2018-07-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-03-11 |
| (46) | Date of publication of the claims translation | 2020-06-10 |
| (30) | Number | Date | Country code |
| 261149 P | 2009-11-13 | US |
| (72) |
HETTMANN, Thore, DE
FREEMAN, Daniel J., US
RADINSKY, Robert, US
|
| (73) |
Amgen, Inc,
One Amgen Center Drive, Thousand Oaks, CA 91320-1799,
US
Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 München, DE |
| (74) |
Virgina Adolfina DRAUGELIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Medžiaga ir būdai, skirti su HER-3 susijusių ligų gydymui ir prevancijai |
| MATERIAL AND METHODS FOR TREATING OR PREVENTING HER-3 ASSOCIATED DISEASES |
| Payment date | Validity (years) | Amount | |
| 2024-10-04 | 15 | 289.00 EUR |
| 2025-11-12 |